We describe “Blinded for peer review” Cancer Center's experience using Bv‐ICE in CD30 (+) PTCL and romidepsin‐ICE in CD30 (−) PTCL. This evidence concerns the gene TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma.